ASI Business Solutions, Inc. v. Otsuka America Pharmaceutical, Inc.

233 F. Supp. 3d 432, 2017 WL 542366, 2017 U.S. Dist. LEXIS 18981
CourtDistrict Court, E.D. Pennsylvania
DecidedFebruary 10, 2017
DocketCIVIL ACTION NO. 16-5514
StatusPublished
Cited by8 cases

This text of 233 F. Supp. 3d 432 (ASI Business Solutions, Inc. v. Otsuka America Pharmaceutical, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
ASI Business Solutions, Inc. v. Otsuka America Pharmaceutical, Inc., 233 F. Supp. 3d 432, 2017 WL 542366, 2017 U.S. Dist. LEXIS 18981 (E.D. Pa. 2017).

Opinion

[434]*434MEMORANDUM

EDUARDO C. ROBRENO, J.

Before the Court is the plaintiffs motion for a preliminary injunction (EOF No. 3). This motion seeks to enjoin the defendant from, among other things, using or disclosing the plaintiffs software, which the defendant had previously licensed from the plaintiff. For the reasons that follow, the Court will deny the motion for a preliminary injunction without prejudice to the plaintiff proceeding on the underlying complaint or seeking permanent injunctive relief, to the extent any such relief is warranted.1

I. FACTUAL BACKGROUND

The plaintiff in this case is ASI Business Solutions, Inc. (“Plaintiff’ or “ASI”), a Pennsylvania corporation that develops, licenses, and implements relationship management software, and provides professional services related to such software. Compl. ¶¶ 2, 6, ECF No. 1. The defendant is Otsuka America Pharmaceutical, Inc. (“Defendant” or “Otsuka”), a Maryland corporation with its principal place of business in Princeton, New Jersey, that researches and develops clinical healthcare products including new treatments and indications focusing on neuroscience, oncology, hospital, and medical device areas for diseases. Id. at ¶¶ 3,12.

ASI claims that its various software products constitute valuable trade secrets that ASI licenses to numerous companies for millions of dollars per year. Id. at ¶ 9. ASI takes extensive measures to protect this valuable software and guard its confidentiality, including “licensing its software only to those companies that agree to maintain the confidentiality of ASI’s software, not to disclose ASI’s software to third parties without ASI’s prior, written permission, and to destroy or remove its software after the termination of the license agreement.” Id, at ¶ 11.

On November 1, 2010, the parties entered into a Master Subscription Agreement (the “Agreement”), under which ASI agreed to license subscription services on a non-exclusive, right-to-use basis at Otsu-ka’s identified facilities. Id at ¶¶ 14, 16. The Agreement allowed Otsuka to license ASI’s products and services from January 1, 2012, to January 31, 2017. Id. at ¶ 21. Pursuant to the Agreement, Otsuka installed ASI software on numerous computers and devices accessible by Otsuka employees. Id at ¶ 22. The Agreement prohibited Otsuka from copying, relocating, moving, sublicensing, renting, time-sharing, loaning, leasing, or distributing the software products it obtained under the Agreement. Id at ¶ 17. It further prohibited Otsuka from operating the subscription service for the benefit of any third party without ASI’s prior written consent, and it made any attempt to do so void. Id. at ¶ 18.

In December 2015, Otsuka opted to terminate the Agreement early, and it paid ASI an early termination fee of over two million dollars. Id. at ¶ 23. Subsequently, Otsuka hired Genpact, a third-party software developer, to develop an alternative to ASI’s software and related services. Id at ¶ 24. ASI and Otsuka originally agreed [435]*435on an early termination date of June 4, 2016, but when Otsuka’s alternative software was not ready by that time, Otsuka paid ASI $175,000 to extend the early termination date to July 4, 2016. Id. at ¶ 25. Otsuka then paid ASI another $175,000 to extend that date to August 4, 2016, and an additional $175,000 to extend that date to September 4, 2016. Id.

Upon termination of the Agreement on September 4, 2016, Otsuka was required to cease using and accessing ASI’s subscription services, including ASI’s trade secret software. Id. at ¶ 26. ASI claims that Otsuka was further required to promptly return to ASI all of ASI’s confidential information and other materials, including preliminary outlines, notes, sketches, plans, unpublished memoranda, and other documents. Id. at ¶ 27. Alternatively, Otsuka could have destroyed all ASI confidential information and delivered a written and signed statement to ASI certifying the destruction. Id In ASI’s view, Otsuka has failed to comply with these unambiguous provisions of the Agreement. Id. at ¶ 28.

On September 26, 2016, Otsuka certified to ASI that it had “ceased using and accessing [ASI’s] Subscription Service” and had “used reasonable business efforts to confirm removal of any ASI Confidential Information, including Intellectual Property.” Id. at ¶ 32. ASI claims that this certification does not fulfill Otsuka’s obligations under the Agreement, and further that Otsuka is a sophisticated corporation that has the necessary expertise to remove and permanently destroy all ASI ■ confidential information from Otsuka’s computer systems. Id. at ¶¶ 33-34.

ASI claims that Otsuka continued to use ASI’s trade secret software to make system-access requests tó ASI even after September 26, 2016. Id. at ¶ 35. On October 3, 2016, ASI’s counsel wrote to Otsuka, reiterating the importance of returning or destroying ASI’s confidential information and requesting that Otsuka comply with the relevant provision of the Agreement. M. at ¶38. Otsuka never responded to.this letter, and as of the date the Complaint was filed (he., October 21, 2016), Otsuka had failed to certify that it has removed ASI Confidential Information from all of its computers and devices.2 Id. at ¶ 39.

Based on the foregoing events, ASI claims that it is entitled to relief under the terms of the Agreement,'the federal Defend Trade Secrets Act, and the Pennsylvania Uniform Trade Secrets Act. Id. at ¶ 46. ASI further claims that it will sustain irreparable harm if no injunctive,relief is granted, but Otsuka will sustain no harm if compelled to comply with the Agreement and prohibited from continuing to use and disclose ASI confidential information. Id at ¶ 47. ASI initially sought, the follQwing preliminary and permanent injunctive relief3; .

1. Require Otsuka to return or destroy and certify the destruction of all ASI Confidential Information ⅛ accordance with the terms of the Agreement;
[436]*4362. Prohibit Otsuka from using any ASI Confidential Information;
3. Require Otsuka to disclose all third parties to whom it disclosed ASI Confidential Information;
4. Require all third parties that have obtained ASI Confidential Information from Otsuka to immediately return all such confidential information to ASI;
5. Prohibit Otsuka from using any software developed by Genpact or any other software developers based on unauthorized use and disclosure of ASI Confidential Information; and
6. Award ASI costs and attorneys’ fees as permitted by applicable law.

Compl. 10-11; see also PL’s Mot. TRO & Prelim. Inj. at 1-2, ECF No. 3.

II. PROCEDURAL HISTORY

ASI filed its complaint concurrently with a motion for a temporary restraining order (“TRO”) and preliminary injunction on Friday, October 21, 2016. ECF Nos. 1, 3, 4. Later that day, the Court held an emergency hearing on ASI’s motion for a TRO. See ECF No. 7. Following the emergency hearing, the Court entered an order denying ASI’s motion for a TRO and scheduling a status and scheduling conference for October 25, 2016, ECF No. 6, and following this conference, the Court entered a scheduling order, ECF No. 8.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Untitled Case
M.D. Pennsylvania, 2026
CRAWFORD v. COUNTY OF CHESTER
E.D. Pennsylvania, 2024
ROMAN v. COUNTY OF CHESTER
E.D. Pennsylvania, 2023
JONES v. SORBU
E.D. Pennsylvania, 2021

Cite This Page — Counsel Stack

Bluebook (online)
233 F. Supp. 3d 432, 2017 WL 542366, 2017 U.S. Dist. LEXIS 18981, Counsel Stack Legal Research, https://law.counselstack.com/opinion/asi-business-solutions-inc-v-otsuka-america-pharmaceutical-inc-paed-2017.